A Clinical trial on Lavangapattai Kudineer in the management of Raththa moolam(Bleeding Hemorrhoids) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli

A Prospective,open labelled, Single arm, Non-randomized, Single centric, Phase II clinical trial to determine the effectiveness of Lavangapattai Kudineer in the management of Raththa Moolam( Bleeding Hemorrhoids) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080709

Enrollment

Registered

2025-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K640- First degree hemorrhoids

Interventions

Intervention1: Lavangapattai Kudineer: DOSAGE:110 ml Trice a day for 10 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who will be having classical symptoms of bleeding piles (1st degree Internal Hemorrhoids) i.e. constipation, Bleeding per anus, Itching in the perianal region. 2.Patients who are all willing to give blood samples at subsequent visit are involved in this study.

Exclusion criteria

Exclusion criteria: 1.Patient having 2nd, 3rd degree internal haemorrhoids. 2.Pregnancy. 3.Fissure in ano. 4.Fistula in ano 5.Rectal Malignancy

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of Raththa Moolam(Bleeding Hemorrhoids) and to determine the therapeutic efficacy of clinical trail drug ( Lavangapattai Kudineer)Timepoint: The outcome will be aimed at reducing the symptoms of Raththa Moolam(Bleeding Hemorrhoids) and to determine the therapeutic efficacy of clinical trail drug ( Lavangapattai Kudineer)	—

Secondary

Measure	Time frame
1. To collect various siddha literatures and modern journals. 2.To evaluate Physiochemical, Phytochemical, Bio Chemical analysis. 3.To evaluate safety profile for acute and sub-acute toxicity of trial drug LAVANGAPATTAI KUDINEER. 4.To study styptic activity of LAVANGAPATTAI KUDINEER. 5.To evaluate siddha parameter and compare the (including Envagai thervu) changes in RATHTHAMOOLAM during trial period. 6.To evaluate modern parametric changes in Raththa Moolam patients. 7.To evaluate the Bio statistical analysis.Timepoint: 6 months	—

Measure

Time frame

1. To collect various siddha literatures and modern journals. 2.To evaluate Physiochemical, Phytochemical, Bio Chemical analysis. 3.To evaluate safety profile for acute and sub-acute toxicity of trial drug LAVANGAPATTAI KUDINEER. 4.To study styptic activity of LAVANGAPATTAI KUDINEER. 5.To evaluate siddha parameter and compare the (including Envagai thervu) changes in RATHTHAMOOLAM during trial period. 6.To evaluate modern parametric changes in Raththa Moolam patients. 7.To evaluate the Bio statistical analysis.Timepoint: 6 months

—

Countries

India

Contacts

Public ContactDr T Komalavalli Alias Mehala

Government Siddha Medical College and Hospital

drpsk_md@yahoo.in9944337757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026